ConductScience.org, home

Paper41514652

Spontaneous cSCC Murine Model Shows Limited Response to PD-1 Blockade and Radiation Combination Therapy.

Hosseini TM and 8 others. Cancers (Basel), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Spontaneous cSCC Murine Model Shows Limited Response to PD-1 Blockade and Radiation Combination Therapy. Papers, record 41514652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41514652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spontaneous cSCC Murine Model Shows Limited Response to PD-1 Blockade and Radiation Combination Therapy.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hosseini TMTara Mhttps://orcid.org/0009-0001-4548-7778
2Ho LLaura
3Pham TBTammy Bhttps://orcid.org/0000-0002-4875-7673
4Molinolo AAlfredohttps://orcid.org/0000-0001-8412-2889
5Jones RRiley
6Vera DDavid
7Sharabi AAndrew
8Park SJSoo J
9Guo TTheresahttps://orcid.org/0000-0002-1689-3275

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
1KL2TR001444-08NIH HHSUnited StatesKL2TR001444PubMed and NIHNIH RePORTER
IRG-19-230-48-IRGAmerican Cancer SocietyPubMedPubMed
1K08CA276999-01A1NIH HHSUnited StatesK08CA276999PubMed and NIHNIH RePORTER

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128819064The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade.Cancer Immunol Res2017https://conductscience.org/library/papers/28819064PubMed
241339105Immunomodulation of UVB-induced regulatory T cells prevents the establishment of squamous cell carcinoma.J Immunother Cancer2025https://conductscience.org/library/papers/41339105PubMed
338511232Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD-L1-expressing head and neck cancer.Mol Oncol2024https://conductscience.org/library/papers/38511232PubMed
434448958Immunotherapy for Non-melanoma Skin Cancer.Curr Oncol Rep2021https://conductscience.org/library/papers/34448958PubMed
541319712Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort study.J Am Acad Dermatol2026https://conductscience.org/library/papers/41319712PubMed
630736857Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.J Immunother Cancer2019https://conductscience.org/library/papers/30736857PubMed
722916792Sequencing and characterization of the FVB/NJ mouse genome.Genome Biol2012https://conductscience.org/library/papers/22916792PubMed
819713956Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.Nat Protoc2009https://conductscience.org/library/papers/19713956PubMed
930497667Cutaneous Squamous Cell Carcinoma.Hematol Oncol Clin North Am2019https://conductscience.org/library/papers/30497667PubMed
1033653716Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity.Cancer Immunol Res2021https://conductscience.org/library/papers/33653716PubMed
1132331425Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.Int J Mol Sci2020https://conductscience.org/library/papers/32331425PubMed
1232793604Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors.Front Cell Dev Biol2020https://conductscience.org/library/papers/32793604PubMed
1334680282Overcoming Resistance to Immunotherapy in Advanced Cutaneous Squamous Cell Carcinoma.Cancers (Basel)2021https://conductscience.org/library/papers/34680282PubMed
1439245360
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.
J Am Acad Dermatol2025https://conductscience.org/library/papers/39245360PubMed
1534208111Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations.Int J Mol Sci2021https://conductscience.org/library/papers/34208111PubMed
1630158594Time-Series Analysis of Tumorigenesis in a Murine Skin Carcinogenesis Model.Sci Rep2018https://conductscience.org/library/papers/30158594PubMed
1727358187Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.Am J Clin Dermatol2016https://conductscience.org/library/papers/27358187PubMed
1829332704Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging.J Am Acad Dermatol2018https://conductscience.org/library/papers/29332704PubMed
1932673170Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629).J Clin Oncol2020https://conductscience.org/library/papers/32673170PubMed
2034592000Epidemiology of advanced cutaneous squamous cell carcinoma.J Eur Acad Dermatol Venereol2022https://conductscience.org/library/papers/34592000PubMed

See all 34 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41514652

GET https://conductscience.org/api/papers/v1/41514652/references?page=2